The structural basis of homo- and heterodimerization of two chemokine receptors: Implications in HIV-1 cell entry
The structural basis of homo- and heterodimerization of two chemokine receptors: Implications in HIV-1 cell entry
批准号:
10455267
负责人:
Mahmoud Nasr
金额:
$75.81万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-08-20 至 2023-01-31
关键词:
Acquired Immunodeficiency SyndromeAffectAgonistAttentionBindingBiological AssayCCR5 geneCXCR4 geneCellsCommunicable DiseasesComplementComplexCouplingCryoelectron MicroscopyCrystallizationDevelopmentDimerizationDissociationDrug DesignDrug TargetingElectrophysiology (science)Fluorescence MicroscopyGTP-Binding ProteinsHIVHIV Envelope Protein gp120HIV InfectionsHIV-1HeterodimerizationHomoHumanImageImmune systemLigandsLipidsMembrane LipidsMolecularNegative StainingNeoplasm MetastasisNeurotensin ReceptorsPhysiologicalPlayPredispositionPreparationProteinsRecording of previous eventsReportingResolutionRoleSamplingStructureT-LymphocyteTechniquesTimeVirusbasecell typechemokinechemokine receptordimerdrug developmentexperimental studyinsightluminescencenanodisknew therapeutic targetnovelparticlepatch clampprotein functionreceptorreconstitutionresponsesingle moleculetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY
The chemokine receptors CCR5 and CXCR4 play essential roles in the human immune system and are
involved in HIV infection and cancer metastasis. Several studies have demonstrated the role of homo- and
heterodimerization of these receptors in modulating protein function by affecting their chemokine sensitivity or
altering their G protein coupling mechanisms. Moreover, the ability of HIV to infect T cells utilizing either
CXCR4 or CCR5 as a co-receptor has been shown to depend on homo- and heterodimerization.
Consequently, the association of these two chemokine receptors has increasingly gained attention for drug
design. At this time, there is no high-resolution structure available for CCR5 or CXCR4 homo- or heterodimers
due to the complexity of the crystallization and sample preparation for EM. In aim 1, we will study the
dimerization of CCR5 protein at both molecular and functional levels. In aim 2, we will study the
heterodimerization of CCR5 and CXCR4. In aim 3, we will develop a nanodisc-based fusion assay. Moreover,
we will image HIV pseudovirus particles binding and fusion with large nanodiscs containing CD4/CCR5 or
CD4/CXCR4.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3390/vaccines11111655
发表时间:
2023-10-28
期刊:
Vaccines
影响因子:
7.8
作者:
[Mabrouk MT, Zidan AA, Aly N, Mohammed MT, Ghantous F, Seaman MS, Lovell JF, Nasr ML]
通讯作者:
Nasr ML
BAX Activation and Oligomerization
-
批准号:8978981
-
项目类别:
-
资助金额:$5.42万
-
财政年份:2015
-
负责人:Mahmoud Nasr
-
依托单位:
海外基金